Clinical trial
A Multi-center, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Generic Entecavir Monotherapy or in Combination With Adefovir for Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy
NCT01341743 is registered in ClinicalTrials.gov with Nanfang Hospital, Southern Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-center, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Generic Entecavir Monotherapy or in Combination With Adefovir for Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy
- Lead sponsor
- Nanfang Hospital, Southern Medical University
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- December 31, 2010
- Completion date
- December 31, 2014
- Enrollment
- 360 (estimated)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.